Publications

Search
Found 368 results
Journal Article
Evans RG. Economic barriers to preventive services: clinical obstacle or fiscal defense? American Journal of Preventive MedicineAm.J.Prev.Med.. 1988;4(4 Suppl):111-20; discussion 121-6.
Morgan SG. Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004. Healthcare policy = Politiques de santeHealthc.Policy.. 2005;1(1):85-99.
Brown PM, Windsor J, Law M. Dollars and sense. Is there a better way to determine private surgical fees in New Zealand?. 2005.
Reid RJ, Schneider D, Barer ML, Hanvelt R, McGrail KM, Pagliccia N, et al. The doctor is out: physician participation in the Rationed Access Day work stoppage in British Columbia, 1998/99. Hospital quarterlyHosp.Q.. 2002;6(2):suppl 3-10; discussion suppl 11.
Lavis JN, Ross SE, Stoddart GL, Hohenadel JM, McLeod CB, Evans RG. Do Canadian civil servants care about the health of populations? American Journal of Public HealthAm.J.Public Health. 2003;93(4):658-663.
Hanley GE, Morgan SG, Hurley J, van Doorslaer E. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada. Health economicsHealth Econ.. 2008;17(12):1379-1392.
Evans RG. Dismal science. Healthcare policy = Politiques de santeHealthc.Policy.. 2009;4(4):19-29.
Evans R. Dismal Science. Healthcare Policy [Commentary]. 2009;4(4):19-29.
Kozyrskyi AL, Black CD, Chateau D, Steinbach C. Discharge outcomes in seniors hospitalized for more than 30 days. Canadian journal on aging = La revue canadienne du vieillissementCan.J.Aging. 2005;24 Suppl 1:107-119.
Morgan SG. Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada. Open medicine : a peer-reviewed, independent, open-access journalOpen Med.. 2007;1(1):e37-45.
Watson D. The Development of a Primary Healthcare Information System to Support Research, Evaluation and Monitoring in British Columbia. Healthcare Policy Special Issue. 2009;5.
Watson DE. The development of a primary healthcare information system to support performance measurement and research in british columbia. Healthcare policy = Politiques de santeHealthc.Policy.. 2009;5 Spec no:16-30.
Kawasumi Y, Abrahamowicz M, Ernst P, Tamblyn R. Development and validation of a predictive algorithm to identify adult asthmatics from medical services and pharmacy claims databases. Health Services Research. 2011;46(3):939-963.
Broemeling A, Kerluke K, Black CD, Peterson S, MacDonald A, McKendry R. Developing and Maintaining a Population Research Registry to Support Primary Healthcare Research. Healthcare Policy Special Issue. 2009;5.
Wang ST, Bhattacharyya O, Wang B, Liu L, Chen B. Developing a Performance Measurement Framework and Indicators for Community Health Service Facilities in Urban China. BMC Family Practice. 2010;11.
Law M., Kawasumi Y, Morgan SG. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov. Health Affairs. 2011;30(12):2338-2345.
Law M., Kawasumi Y, Morgan SG. Despite Law, Fewer Than One In Eight Completed Studies Of Drugs And Biologics Are Reported On Time On Clinical Trials. Health Affairs. 2011;30(12):2338-2345.
Sivananthan SN, Peterson S, Lavergne R, Barer ML, McGrail KM. Designation, diligence and drift: understanding laboratory expenditure increases in British Columbia, 1996/97 to 2005/06. BMC Health Services Research. 2012;12.
Lewis S, Baird P, Evans RG, Ghali WA, Wright CJ, Gibson E, et al. Dancing with the porcupine: rules for governing the university-industry relationship. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2001;165(6):783-785.
Chamberlayne R, Green B, Barer ML, Hertzman C, Lawrence WJ, Sheps SB. Creating a population-based linked health database: a new resource for health services research. Canadian journal of public health.Revue canadienne de sante publiqueCan.J.Public Health. 1998;89(4):270-273.
Law M., Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of Internal MedicineArch.Intern.Med.. 2009;169(21):1969-1974.
Law M., Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Archives of internal medicine. 2009;169(21):1969.
Morgan SG, Kennedy J. Cost-Related Prescription Nonadherence in the United States and Canada. Clinical Therapeutics. 2009;31(1):213-219.
Kratzer J, McGrail K, Strumpf E, Law MR. Cost-Control Mechanisms in Canadian Private Drug Plans. Healthcare Policy. 2013;9(1):35-43.
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.

Pages